AbbVie Inc.
Manufacturer / marketing-authorisation holder
AbbVie Inc. — 111 products across 3 markets, 33 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
AbbVie Inc. — 111 productos en 3 mercados, 33 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
AbbVie Inc. —— 共 111 个产品,覆盖 3 个市场、33 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
111 products · 3 markets · 33 brand names
111 productos · 3 mercados · 33 marcas
111 个产品 · 3 个市场 · 33 个品牌名
Products by country
US
Source: api.fda.gov
CN
Source: code.nhsa.gov.cn
| Brand | Active ingredient(s) | Form |
|---|---|---|
| — | 酒石酸溴莫尼定 | liquid |
| 唯可来 | 维奈克拉 | tablet |
| 唯可来 | 维奈克拉 | tablet |
| 唯可来 | 维奈克拉 | tablet |
| 唯可来 | 维奈克拉 | tablet |
| 爱拉赫 | 索米妥昔单抗 | injection |
MX
Source: www.gob.mx
| Brand | Active ingredient(s) | Form |
|---|---|---|
| Aquipta 60mg tablets | Atogepant | tablet |
| EPKINLY | Epcoritamab | liquid |
| KIREBA | 利巴韦林 | tablet |
| RIM-VOQ | Upadacitinib | tablet |
| Skyrizi | Risankizumab | liquid |
| VIEKIRA PAK | 达塞布韦钠 + Ombitasvir + Paritaprevir | tablet |
Showing the first 32 of 111 products (ordered by country).
Mostrando los primeros 32 de 111 productos (orden por país).
仅显示前 32 / 111 个产品(按国家排序)。